You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 2, February 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (74)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Quinidine Therapy of Chronic Auricular Fibrillation

The Occurrence and Mechanism of Syncope

R. ROKSETH, M.D.; O. STORSTEIN, M.D.

Arch Intern Med. 1963;111(2):184-189.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The purpose of this paper is to review the results of quinidine therapy in 274 unselected patients with established auricular fibrillation. There is still a diversity of opinion regarding the indications for quinidine and the factors influencing successful therapy.1-6 The risks of quinidine also present problems. The occurrence of embolism after conversion to sinus rhythm has probably been exaggerated. Can the routine use of anticoagulants further reduce the danger? How frequent is syncope, and how efficient are immediate measures, such as artificial respiration, closed-chest cardiac massage, and appropriate drugs, in preventing sudden death, ascribable to quinidine?

Methods

During 6 years, all patients in our medical department with persistent fibrillation were treated with quinidine. The only contraindication was total atrioventricular block. All patients were digitalized, and the signs of congestive heart failure were reduced as far as possible by salt restriction, mercurial diuretics, aminophylline, etc., before conversion was attempted. Anticoagulants . . . [Full Text PDF of this Article]


Author Affiliations

OSLO, NORWAY

Assistant physician (Dr. Rokseth) and Director (Dr. Storstein), Cardio-pulmonary Laboratory, University Hospital, Oslo, Norway.; From the Medical Department, Nordland County Hospital, Bodö, Norway.


Footnotes

Received for publication May 22, 1962; accepted Sept. 13.

Present address: Rikshospitalet, Oslo, Norway.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.